Description
FSC GROUP 65, PART I, SECTION B DRUGS, PHARMACEUTICALS&HEMATOLOGY RELATED PRODUCTS
Base award description: PHARMACEUTICAL PRODUCTS
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-10-02+$0= $0
- Mod 462009-06-08+$0= $0
- Mod 762010-06-08+$0= $0
- Mod 932010-11-22+$0= $0
- Mod 1042011-03-18+$0= $0
- Mod 1332011-09-09+$0= $0
- Mod PO01482012-01-25+$0= $0
- Mod PO01512012-02-24+$0= $0
- Mod P001522012-03-23+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base· NOVATION AGREEMENT | 2008-10-02 | +$0 | $0 | PHARMACEUTICAL PRODUCTS |
| Mod 46· EXERCISE AN OPTION | 2009-06-08 | +$0 | $0 | FCS GROUP 65, PART I, SECTION B - DRUGS, PHARMACEUTICALS & HEMATOLOGY RELATED PRODUCTS |
| Mod 76· EXERCISE AN OPTION | 2010-06-08 | +$0 | $0 | FSC GROUP 65, PART I, SECTION B DRUGS, PHARMACEUTICALS & HEMATOLOGY RELATED PRODUCTS |
| Mod 93· EXERCISE AN OPTION | 2010-11-22 | +$0 | $0 | FSC GROUP 65, PART I, SECTION B DRUGS, PHARMACEUTICALS&HEMATOLOGY RELATED PRODUCTS |
| Mod 104· EXERCISE AN OPTION | 2011-03-18 | +$0 | $0 | FSC GROUP 65, PART I, SECTION B DRUGS, PHARMACEUTICALS&HEMATOLOGY RELATED PRODUCTS |
| Mod 133· EXERCISE AN OPTION | 2011-09-09 | +$0 | $0 | FSC GROUP 65, PART I, SECTION B DRUGS, PHARMACEUTICALS&HEMATOLOGY RELATED PRODUCTS |
| Mod PO0148· EXERCISE AN OPTION | 2012-01-25 | +$0 | $0 | FSC GROUP 65, PART I, SECTION B DRUGS, PHARMACEUTICALS&HEMATOLOGY RELATED PRODUCTS |
| Mod PO0151· EXERCISE AN OPTION | 2012-02-24 | +$0 | $0 | FSC GROUP 65, PART I, SECTION B DRUGS, PHARMACEUTICALS&HEMATOLOGY RELATED PRODUCTS |
| Mod P00152· EXERCISE AN OPTION | 2012-03-23 | +$0 | $0 | FSC GROUP 65, PART I, SECTION B DRUGS, PHARMACEUTICALS&HEMATOLOGY RELATED PRODUCTS |
Related awards · 10
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UBC2KGMNU578)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77020N0051 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $19,994 | FY2020 |
| V797D70253 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
| V797P2107D | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2012 |
| VA25612P0311 | 502-ALEXANDRIA · 6505 · DRUGS AND BIOLOGICALS | $3,992 | FY2012 |
| VA678P15376 | 678-TUCSON · 6505 · DRUGS AND BIOLOGICALS | $5,120 | FY2011 |
Other recipients under 6505 from DEPT OF VETERANS AFFAIRS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA797P16J0052 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $71,957 | FY2016 |
| VA797P16J0053 | EXCELLIUM PHARMACEUTICAL INC. | DEPT OF VETERANS AFFAIRS | $69,294 | FY2016 |
| VA797P16J0051 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC | DEPT OF VETERANS AFFAIRS | $227,935 | FY2016 |
| VA797P16J0050 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $22,663 | FY2016 |
| VA797P16J0049 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $32,995 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_V797P5669X_3600 · retrieved 2026-09-26.